User menu

A Randomized Controlled Trial of Selective Neurotomy Versus Botulinum Toxin for Spastic Equinovarus Foot After Stroke.

Bibliographic reference Bollens, Benjamin ; Gustin, Thierry ; Stoquart, Gaëtan ; Detrembleur, Christine ; Lejeune, Thierry ; et. al. A Randomized Controlled Trial of Selective Neurotomy Versus Botulinum Toxin for Spastic Equinovarus Foot After Stroke.. In: Neurorehabilitation and neural repair, Vol. 27, no. 8, p. 695-703 (2013)
Permanent URL http://hdl.handle.net/2078.1/131321
  1. Strong Kathleen, Mathers Colin, Bonita Ruth, Preventing stroke: saving lives around the world, 10.1016/s1474-4422(07)70031-5
  2. Schinwelski M, Neurol Neurochir Pol, 44, 404 (2010)
  3. Verdié C., Daviet J.C., Borie M.J., Popielarz S., Munoz M., Salle J.Y., Rebeyrotte I., Dudognon P., Épidémiologie des pieds varus et/ou équin un an après un premier accident vasculaire cérébral hémisphérique : à propos d'une cohorte de 86 patients, 10.1016/j.annrmp.2003.10.005
  4. Deltombe Thierry, Gustin Thierry, De Cloedt Philippe, Vandemeulebroecke Maryse, Hanson Philippe, The Treatment of Spastic Equinovarus Foot after Stroke, 10.1615/critrevphysrehabilmed.v19.i3.20
  5. Burbaud P, Wiart L, Dubos J L, Gaujard E, Debelleix X, Joseph P A, Mazaux J M, Bioulac B, Barat M, Lagueny A, A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients., 10.1136/jnnp.61.3.265
  6. Pittock S.J., Moore A.P., Hardiman O., Ehler E., Kovac M., Bojakowski J., al Khawaja I., Brozman M., Kaňovský P., Skorometz A., Slawek J., Reichel G., Stenner A., Timerbaeva S., Stelmasiak Z., Zifko U.A., Bhakta B., Coxon E., A Double-Blind Randomised Placebo-Controlled Evaluation of Three Doses of Botulinum Toxin Type A (Dysport®) in the Treatment of Spastic Equinovarus Deformity after Stroke, 10.1159/000069495
  7. Dunne John Walter, Gracies Jean-Michel, Hayes Michael, Zeman Brian, Singer Barbara Jennifer, , A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after stroke, 10.1177/0269215511432016
  8. Mohammadi B., Abdoulrahmani Balouch S., Dengler R., Kollewe K., Long-term treatment of spasticity with botulinum toxin type A: an analysis of 1221 treatments in 137 patients, 10.1179/016164109x12478302362734
  9. Lejeune TM, Bollens B, Deltombe T, Detrembleur C, Gustin T, Stoquart G, Effects of selective tibial nerve neurotomy as a treatment for adults presenting with spastic equinovarus foot: a systematic review, 10.2340/16501977-0786
  10. Decq Philippe, Cuny Emmanuel, Filipetti Paul, Kéravel Yves, Role of soleus muscle in spastic equines foot, 10.1016/s0140-6736(98)85025-3
  11. Deltombe T, Decq P, Mertens P, Gustin T, Does fascicular neurotomy have long-lasting effects?, 10.2340/16501977-0073
  12. World Health Organization, International Classification of Functioning, Handicap and Health (2001)
  13. Deltombe Thierry, De Wispelaere Jean-François, Gustin Thierry, Jamart Jacques, Hanson Philippe, Selective blocks of the motor nerve branches to the soleus and tibialis posterior muscles in the management of the spastic equinovarus foot11No commercial party having a direct financial interest in the results of the research supporting this article has conferred or will confer a financial benefit on the author(s) or on any organization with which the author(s) is/are associated., 10.1016/s0003-9993(03)00405-2
  14. Pocock Stuart J., Simon Richard, Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial, 10.2307/2529712
  15. Chino N, Functional Evaluation of Stroke Patient, 1996, 19
  16. Deltombe Thierry, Gustin Thierry, Selective Tibial Neurotomy in the Treatment of Spastic Equinovarus Foot in Hemiplegic Patients: A 2-Year Longitudinal Follow-Up of 30 Cases, 10.1016/j.apmr.2010.04.010
  17. Lehmann JF, Arch Phys Med Rehabil, 70, 6 (1989)
  18. Detrembleur Christine, Plaghki Léon, Quantitative assessment of intrathecally administered baclofen in spasticity, 10.1016/s0003-9993(00)90071-6
  19. Tardieu G, Rev Neurol, 91, 143 (1954)
  20. Bohannon Richard W., Smith Melissa B., Interrater Reliability of a Modified Ashworth Scale of Muscle Spasticity, 10.1093/ptj/67.2.206
  21. Demeurisse G., Demol O., Robaye E., Motor Evaluation in Vascular Hemiplegia, 10.1159/000115178
  22. Wade DT, Curr Opin Neurol Neurosurg, 5, 682 (1992)
  23. Stoquart G., Detrembleur C., Lejeune T., Effect of speed on kinematic, kinetic, electromyographic and energetic reference values during treadmill walking, 10.1016/j.neucli.2008.02.002
  24. Detrembleur C., Dierick F., Stoquart G., Chantraine F., Lejeune T., Energy cost, mechanical work, and efficiency of hemiparetic walking, 10.1016/s0966-6362(02)00193-5
  25. Perry J., Garrett M., Gronley J. K., Mulroy S. J., Classification of Walking Handicap in the Stroke Population, 10.1161/01.str.26.6.982
  26. Holden Maureen K., Gill Kathleen M., Magliozzi Marie R., Nathan John, Piehl-Baker Linda, Clinical Gait Assessment in the Neurologically Impaired, 10.1093/ptj/64.1.35
  27. Caty Gilles D., Arnould Carlyne, Stoquart Gaëtan G., Thonnard Jean-Louis, Lejeune Thierry M., ABILOCO: A Rasch-Built 13-Item Questionnaire to Assess Locomotion Ability in Stroke Patients, 10.1016/j.apmr.2007.08.155
  28. Rééducation neurologique, 10.1016/j.annrmp.2005.07.038
  29. Ware JE, How to score version 2 of the SF-36 Health Survey (Standard and Acute Forms) (2001)
  30. Folstein Marshal F., Folstein Susan E., McHugh Paul R., “Mini-mental state”, 10.1016/0022-3956(75)90026-6
  31. Rousseaux M., Buisset N., Daveluy W., Kozlowski O., Blond S., Comparison of botulinum toxin injection and neurotomy in patients with distal lower limb spasticity, 10.1111/j.1468-1331.2008.02112.x